MedWatch

Hearing aid CEO predicts big rebound after virus year and massive costs shutting down subsidiary

The Covid-19 pandemic and costs relating to shutting down a Chinese subsidiary in 2020 have been costly for Estron, which provides equipment to large hearing aid companies. 2021 will be more positive, predicts the CEO, who estimates that the operating result will more than double.

Estron Managing Director, CEO, Kim Nyborg Carlsen | Photo: Estron / PR

Read this article for free

Register with your E-mail.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

WS Audiology plans to list subsidiary

Privately-owned hearing aid company WS Audiology, which grew out of the merger between Widex and Sivantos, plans to list Hear.com, which handles online sales.

Further reading

Related articles

Latest news

See all jobs